- Home
- IMRN vs MYSE Comparison
IMRN vs MYSE Comparison
Compare IMRN & MYSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- MYSE
- Stock Information
- Founded
- IMRN 1994
- MYSE 2014
- Country
- IMRN Australia
- MYSE United States
- Employees
- IMRN N/A
- MYSE N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- MYSE Telecommunications Equipment
- Sector
- IMRN Health Care
- MYSE Telecommunications
- Exchange
- IMRN Nasdaq
- MYSE Nasdaq
- Market Cap
- IMRN 9.2M
- MYSE 8.9M
- IPO Year
- IMRN N/A
- MYSE 2021
- Fundamental
- Price
- IMRN $1.80
- MYSE $2.14
- Analyst Decision
- IMRN Strong Buy
- MYSE
- Analyst Count
- IMRN 1
- MYSE 0
- Target Price
- IMRN $5.00
- MYSE N/A
- AVG Volume (30 Days)
- IMRN 46.0K
- MYSE 48.2K
- Earning Date
- IMRN 08-29-2025
- MYSE 11-13-2025
- Dividend Yield
- IMRN N/A
- MYSE N/A
- EPS Growth
- IMRN N/A
- MYSE N/A
- EPS
- IMRN N/A
- MYSE N/A
- Revenue
- IMRN $4,777,422.00
- MYSE $315.00
- Revenue This Year
- IMRN N/A
- MYSE N/A
- Revenue Next Year
- IMRN N/A
- MYSE N/A
- P/E Ratio
- IMRN N/A
- MYSE N/A
- Revenue Growth
- IMRN 48.63
- MYSE N/A
- 52 Week Low
- IMRN $1.50
- MYSE $1.15
- 52 Week High
- IMRN $2.87
- MYSE $9.34
- Technical
- Relative Strength Index (RSI)
- IMRN 48.13
- MYSE N/A
- Support Level
- IMRN $1.80
- MYSE N/A
- Resistance Level
- IMRN $1.94
- MYSE N/A
- Average True Range (ATR)
- IMRN 0.08
- MYSE 0.00
- MACD
- IMRN -0.01
- MYSE 0.00
- Stochastic Oscillator
- IMRN 22.22
- MYSE 0.00
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About MYSE Myseum Inc. Common Stock
Myseum Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts.